Atherosclerotic Risk Factor Prevalence in Adults With Congenital Heart Disease: A Meta-Analysis

Andreas S Papazoglou1, Konstantinos G Kyriakoulis2, Konstantinos Barmpagiannos3

  • 1Athens Naval Hospital, Athens, Greece.

JACC. Advances
|November 5, 2024
PubMed

Insights

Adults with congenital heart disease (ACHD) have similar atherosclerotic cardiovascular disease (ASCVD) risk factors as the general population. Exceptions include higher diabetes mellitus rates and lower smoking rates in ACHD patients.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Adults with congenital heart disease (ACHD) face risks of atherosclerotic cardiovascular disease (ASCVD) comparable to the general population.
  • These risks are primarily influenced by traditional ASCVD risk factors.

Purpose of the Study:

  • To determine the prevalence of traditional ASCVD risk factors in ACHD patients.
  • To compare the prevalence of these risk factors in ACHD patients with the general population.

Main Methods:

  • A systematic literature search identified relevant studies up to May 15, 2024.
  • Meta-analyses synthesized prevalence data and compared ACHD patients with control groups where available.

Main Results:

  • The study analyzed 62 studies involving 110,469 ACHD patients.
  • Prevalence rates were similar between ACHD patients and controls for hypertension, dyslipidemia, obesity, and physical inactivity.
  • Notably, ACHD patients showed a higher prevalence of diabetes mellitus and a lower prevalence of smoking compared to controls.

Conclusions:

  • Traditional ASCVD risk factor prevalence, excluding diabetes mellitus and smoking, is comparable between ACHD patients and the general population.
  • Further research is required to ascertain the efficacy of general population interventions for ASCVD risk reduction in ACHD patients.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
150
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2